St. Francis Cancer Center | St. Francis Cancer Center | A051301
st francis cancer center, cancer center greenville sc, cancer care greenville sc, aya cancer care, aya cancer care greenville sc
1984
clinical-trial-template-default,single,single-clinical-trial,postid-1984,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-3.9,wpb-js-composer js-comp-ver-5.4.7,vc_responsive

Clinical Trials

A051301

A051301 – A randomized double-blind phase III study of ibrutinib during and following autologous stem cell transplantation versus placebo in patients with relapsed or refractory diffuse large B-Cell lymphoma of the activated B-Cell subtype

Screening Consent to Test Tissue Samples for Subtype Determination for A051301…read more>

« Available Clinical Trials